Development of an effective palladium removal process for VEGF oncology candidate AG13736 and a simple, efficient screening technique for scavenger reagent identification

被引:56
作者
Flahive, Erik J. [1 ]
Ewanicki, Brigitte L. [1 ]
Sach, Neal W. [2 ]
O'Neill-Slawecki, Stacy A. [1 ]
Stankovic, Nebojsa S. [1 ]
Yu, Shu [1 ]
Guinness, Steven M. [3 ]
Dunn, Jonathan [4 ]
机构
[1] Pfizer Global R&D, Chem Res & Dev, San Diego, CA 92121 USA
[2] Pfizer Global R&D, Chem Res & Dev, Groton, CT 06340 USA
[3] Pfizer Global R&D, Chem Res & Dev, Sandwich CT13 9NJ, Kent, England
[4] Pfizer Global R&D, Analyt Res & Dev, San Diego, CA 92121 USA
关键词
D O I
10.1021/op600280g
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
AG13736 (Axitinib), an inhibitor of vascular endothelial growth factor (VEGF) under investigation as an oncology drug, is currently manufactured via a three-step process that utilizes two palladium-mediated cross-couplings. Historically, removal of residual heavy metals from the active pharmaceutical ingredient has been a persistent issue. The development of a much improved process for palladium removal and a useful screening technique developed to rapidly identify the most efficient reagents for this purpose are outlined. The performance of the new endgame process in pilot-plant scale-up is also discussed.
引用
收藏
页码:637 / 645
页数:9
相关论文
共 9 条
[1]  
Bien JT, 2004, TOP ORGANOMETAL CHEM, V6, P263
[2]   Vascular endothelial growth factor as a target for anticancer therapy [J].
Ferrara, N .
ONCOLOGIST, 2004, 9 :2-10
[3]   A high-throughput chelating agents for methodology for screening solution-based efficient palladium removal [J].
Flahive, Erik ;
Ewanicki, Brigitte ;
Yu, Shu ;
Higginson, Paul D. ;
Sach, Neal W. ;
Morao, Inaki .
QSAR & COMBINATORIAL SCIENCE, 2007, 26 (05) :679-685
[4]   The art of meeting palladium specifications in active pharmaceutical ingredients produced by Pd-catalyzed reactions [J].
Garrett, CE ;
Prasad, K .
ADVANCED SYNTHESIS & CATALYSIS, 2004, 346 (08) :889-900
[5]   A practical synthesis of 6-[2-(2,5-dimethoxyphenyl)ethyl]-4-ethylquinazoline and the art of removing palladium from the products of Pd-catalyzed reactions [J].
Königsberger, K ;
Chen, GP ;
Wu, RR ;
Girgis, MJ ;
Prasad, K ;
Repic, O ;
Blacklock, TJ .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2003, 7 (05) :733-742
[6]   Large-scale Negishi coupling as applied to the synthesis of PDE472, an inhibitor of phosphodiesterase type 4D [J].
Manley, PW ;
Acemoglu, M ;
Marterer, W ;
Pachinger, W .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2003, 7 (03) :436-445
[7]   Cross-coupling methods for the large-scale preparation of an imidazole-thienopyridine:: Synthesis of [2-(3-methyl-3H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]-(2-methyl-1H-indol-5-yl)-amine [J].
Ragan, JA ;
Raggon, JW ;
Hill, PD ;
Jones, BP ;
McDermott, RE ;
Munchhof, MJ ;
Marx, MA ;
Casavant, JM ;
Cooper, BA ;
Doty, JL ;
Lu, Y .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2003, 7 (05) :676-683
[8]   A novel methodology for efficient removal of residual palladium from a product of the Suzuki-Miyaura coupling with polymer-supported ethylenediamine derivatives [J].
Urawa, Y ;
Miyazawa, M ;
Ozeki, N ;
Ogura, K .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2003, 7 (02) :191-195
[9]   Adsorbent screening for metal impurity removal in pharmaceutical process research [J].
Welch, CJ ;
Albaneze-Walker, J ;
Leonard, WR ;
Biba, M ;
DaSilva, J ;
Henderson, D ;
Laing, B ;
Mathre, DJ ;
Spencer, S ;
Bu, XD ;
Wang, TB .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2005, 9 (02) :198-205